This study tests a new gel called HY209 for people with mild to moderate atopic dermatitis (eczema). About 210 adults will use the gel or a placebo to see if it improves their skin condition. The goal is to find a safe and effective treatment to control eczema symptoms.
Phase: PHASE2 • Sponsor: Shaperon • Aim: Disease control
Last updated May 14, 2026 12:03 UTC